Xoft, a subsidiary of iCAD, Inc.
Our transformative vision for the future of radiation therapy began with the breakthrough development of our miniaturized x-ray source – so small, it could fit on the tip of your finger. Today, this proprietary technology, combined with the comprehensive capabilities of the Xoft System, has powered the treatment of thousands of cancer patients worldwide. Every component of our advanced platform technology has been expertly engineered to improve quality of care, optimize operational workflow, and increase access to patient-centric, cutting-edge radiation therapy for patients and providers alike – all in one, innovative system.
Our technology empowers physicians with full confidence to precisely and effectively treat cancer and enable their patients to live healthy, high-quality lives. Our commitment to this innovative technology is driven by the valuable benefits it offers to physicians, facilities and patients on a global scale.
What is Electronic Brachytherapy (eBx)
The term brachytherapy means 'near therapy,' or bringing the source of radiation close to the tissue that is targeted. The goal is to direct the radiation dose to the size and shape of the cancerous area, sparing healthy tissue and organs. This is contrasted with external beam, or linear accelerator technology, which delivers treatment from outside the body. The comprehensive capabilities of the Xoft System offer an attractive option to physicians and patients for improved flexibility, precision and personalization in the targeted treatment of cancer.